OpenRiskNet/NanoCommons ontology meeting
13 - 14 December 2018
Brussels, BelgiumOpenRiskNet/NanoCommons ontology meeting https://openrisknet.org/events/45/ https://tess.elixir-europe.org/events/openrisknet-nanocommons-ontology-meeting The goal of this meeting is to get a picture of the ongoing ontology activities in the toxicology area, harmonize these efforts and the developed ontologies therein, and extend the existing toxicology ontology to support OpenRiskNet and NanoCommons tasks. Part of this will be the ontological annotation of OpenRiskNet Application Programming Interfaces (APIs) as used on their cloud. Other goals include extension of the ontology with missing terms (if any), potentially write up guidance documents, and annotation of data sets (possible via OpenRiskNet data APIs). 2018-12-13 13:00:00 UTC 2018-12-14 14:00:00 UTC University of Birmingham office in Brussels, Brussels, Belgium University of Birmingham office in Brussels Brussels Belgium Ontology and terminology Toxicology  NanoCommonsOpenRiskNetH2020  workshops_and_courses  risk assessmentnanosafetydata annotationservice descriptions
Type 2 Immunity in Homeostasis and Disease
21 - 22 February 2019
Brugge, BelgiumType 2 Immunity in Homeostasis and Disease https://vibconferences.be/event/type-2-immunity-in-homeostasis-and-disease https://tess.elixir-europe.org/events/type-2-immunity-in-homeostasis-and-disease Type 2 inflammation rich in eosinophils, basophils and mast cells and orchestrated by Th2 lymphocytes has been mainly studied in the context of allergies and immune responses to helminths. Since the discovery of type 2 innate lymphoid cells there has been a strong interest in understanding how type 2 immunity is induced and regulated, for example by barrier epithelial cells. Given the recent introduction of new biologics that target type 2 cytokines to treat severe allergic disease, we are accumulating a lot of new insights on type 2 immune responses in humans as well. This meeting will not only focus on new effector and regulatory mechanisms of the type 2 immune response. It will also offer a number of talks taking a broader look on type 2 immunity, dealing with such topics as type 2 immunity in homeostasis, growth and repair, metabolism, neuro-immune interactions and cancer. Understanding these alternative roles for type 2 immunity will be important to address the benefits and potential pitfalls of long-term inhibition of type 2 immunity by biologicals and could elucidate new therapeutic pathways for very common diseases like asthma, obesity, diabetes and cancer. Abstracts can be submitted for the following topics: Tissue homeostasis and repair Type 2 Neuro-immune axis Type 2 in allergy, asthma & helminth infection Type 2 Immunity & Cancer Deadlines: • Early Bird: 10 January 2019 • Late Registration: 7 February 2019 • Abstract deadline: 19 December 2018 2019-02-21 08:00:00 UTC 2019-02-22 18:00:00 UTC VIB Conferences OLD ST. JOHN SITE, Zonnekemeers, Brugge, Belgium OLD ST. JOHN SITE, Zonnekemeers Brugge West-Vlaanderen Belgium 8000 VIBGhent UniversityCell Press firstname.lastname@example.org Vector Builder  meetings_and_conferences  ImmunityCancer, Cancer Biomarkers, Cancer Biomarkers in Clinical Use, Types of Biomarker and Biomarkers, Surgical oncology, Pediatric Oncology, Haematologist-oncology, Gynecologist oncology, Orthopaedic Oncology, Breast Cancer, Neuro-oncology, Pathophysiology of Cancer, Cancer Pharmacology, Cancer Therapeutics, Homeopathy Cancer Treatment Cancer Epigenetics, Cancer: Lifestyle and Nutrition, Cancer Prognosis and Predictive Factor, Cancer Proteomics, Molecular Epidemiology of Cancer, Cancer Nursing and Care, Cancer Diagnosis, Cancer Biopsy, Magnetic Resonance Imaging (MRI),Factors Associated with Cancer Prevalence, Cancer Pharma Industry, Economic Impact on CancerAllergyAsthmaType 2 immunity
Note, this map only displays events that have geolocation information in TeSS.
For the complete list of events in TeSS, click the grid tab.